Senate Bill 657
116th Congress(2019-2020)
A bill to amend title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits.
Introduced
Introduced in Senate on Mar 5, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
657
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
This bill prohibits health insurers and contracted entities that provide pharmacy benefits management services from receiving a price reduction or other remuneration from prescription drug manufacturers. The prohibition does not apply if (1) the price reduction is reflected at the point-of-sale; and (2) the other remuneration is a transparent, flat service fee that the manufacturer pays in relation to pharmacy benefits management services.
March 5, 2019
03/05/2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
03/05/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 5:17:27 PM